Abstract

In the issue of 15 February (p. 16) we said that the product licences for two oral contraceptives do not allow their use in post-coital contraception. This is untrue. Product licences issued under the Medicines Act in no way restrict the therapeutic uses of medicines: prescribers are free to use them for any purpose they consider appropriate. We had intended to say that the licences do not allow the manufacturers to promote or otherwise mention the use of their products for post-coital contraception.